Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children With Autism

NCT05540574 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05540574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05540574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Placebo-Controlled Crossover Trial of Zolpidem for Sleep in Children With Autism
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Recruiting
Start date
August 9, 2023
Completion date
April 30, 2028
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism, autism spectrum disorder